Effects of dezocine and sufentanyl for postoperative analgesia on activity of NK, CD4+ and CD8+ cells in patients with breast cancer
- PMID: 30867775
- PMCID: PMC6396157
- DOI: 10.3892/ol.2019.9964
Effects of dezocine and sufentanyl for postoperative analgesia on activity of NK, CD4+ and CD8+ cells in patients with breast cancer
Abstract
The effects of dezocine and sufentanyl on the activity of natural killer (NK), CD4+ and CD8+ cells in patients with breast cancer undergoing postoperative analgesia after radical mastectomy were compared. The clinical data of 76 female patients undergoing radical mastectomy in the Fudan University Shanghai Cancer Center from January 2015 to October 2017 were analyzed retrospectively. Forty-two patients treated with dezocine were group D and 34 patients with sufentanyl were group S. Visual analogue scale (VAS) was used to evaluate the analgesic effect at 3, 12, 24, 48 h after surgery. There was no significant difference in VAS score, NK cells, CD4+ cells, and CD8+ cell vitality at 3 h postoperatively between the two groups (P>0.05), and VAS score at 12, 24 and 48 h postoperatively in the S group was significantly lower than that in group D (P<0.05). The activity of NK cells and CD4+ cells at 3, 12, 24 and 48 h after surgery in group D was significantly higher than that in group S, and the difference was statistically significant (P<0.05). The activity of CD8+ cells at 3, 12, 24 and 48 h after surgery in group D was significantly lower than that in group S, and the difference was statistically significant (P<0.05). The analgesic effect of dezocine was slightly worse than that of sufentanyl, but it was more beneficial to the recovery of early postoperative immune function.
Keywords: CD4+; CD8+; NK cells; breast cancer; dezocine; postoperative analgesia; sufentanyl.
Figures




Similar articles
-
Effects of dexmedetomidine combined with dezocine on T lymphocytes, NK cells and cognitive function in elderly patients with gastrointestinal cancer after radical surgery.Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):56-62. doi: 10.14715/cmb/2023.69.10.7. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37953585 Clinical Trial.
-
Analgesic effect of dezocine in different doses on elderly patients undergoing abdominal operation under general anesthesia and its influence on stress response to postoperative tracheal extubation.Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5223-5229. doi: 10.26355/eurrev_201711_13845. Eur Rev Med Pharmacol Sci. 2017. PMID: 29228438 Clinical Trial.
-
Oxycodone versus dezocine for postoperative analgesia in patients with cervical cancer treated with radical surgery.J Cancer Res Ther. 2016 Oct;12(Supplement):27-29. doi: 10.4103/0973-1482.191624. J Cancer Res Ther. 2016. PMID: 27721247
-
Efficacy and safety of different doses of dezocine for preemptive analgesia in gynecological laparoscopic surgeries: A prospective, double blind and randomized controlled clinical trial.Int J Surg. 2017 Jan-Dec;37 Suppl 1:539-545. doi: 10.1016/j.ijsu.2017.09.079. Epub 2017 Oct 31. Int J Surg. 2017. PMID: 29097325 Clinical Trial.
-
Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1989 Aug;38(2):226-48. doi: 10.2165/00003495-198938020-00005. Drugs. 1989. PMID: 2670517 Review.
Cited by
-
Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway.Toxicol Res (Camb). 2022 May 30;11(3):498-510. doi: 10.1093/toxres/tfac026. eCollection 2022 Jun. Toxicol Res (Camb). 2022. PMID: 35782639 Free PMC article.
-
Comparison of postoperative analgesia between dezocine plus flurbiprofen axetil and sufentanil in patients with CRC undergoing tumor resection: A prospective, observational study.Oncol Lett. 2025 Jan 7;29(3):121. doi: 10.3892/ol.2025.14869. eCollection 2025 Mar. Oncol Lett. 2025. PMID: 39807102 Free PMC article.
-
Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery.Drug Des Devel Ther. 2021 Dec 2;15:4925-4938. doi: 10.2147/DDDT.S326891. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34880602 Free PMC article.
-
Comparison of the analgesic effect of dezocine and esketamine in combination with sufentanil respectively after laparoscopic cholecystectomy: a prospective randomized controlled study.BMC Anesthesiol. 2024 Feb 5;24(1):51. doi: 10.1186/s12871-024-02430-y. BMC Anesthesiol. 2024. PMID: 38317099 Free PMC article. Clinical Trial.
-
Dezocine Has the Potential to Regulate the Clinical and Biological Features of Tumors.Drug Des Devel Ther. 2022 Apr 20;16:1121-1129. doi: 10.2147/DDDT.S356863. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35478934 Free PMC article.
References
-
- Kehlet H, Gray AW, Bonnet F, Camu F, Fischer HB, McCloy RF, Neugebauer EA, Puig MM, Rawal N, Simanski CJ. A procedure-specific systematic review and consensus recommendations for postoperative analgesia following laparoscopic cholecystectomy. Surg Endosc. 2005;19:1396–1415. doi: 10.1007/s00464-004-2173-8. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials